C. Fontaine

发表

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

R. Paridaens, H. Wildiers, J. Canon, 2010, Breast Cancer Research and Treatment.